DE602004016292D1 - Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern - Google Patents
Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugernInfo
- Publication number
- DE602004016292D1 DE602004016292D1 DE602004016292T DE602004016292T DE602004016292D1 DE 602004016292 D1 DE602004016292 D1 DE 602004016292D1 DE 602004016292 T DE602004016292 T DE 602004016292T DE 602004016292 T DE602004016292 T DE 602004016292T DE 602004016292 D1 DE602004016292 D1 DE 602004016292D1
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- oxide
- composition
- mammals
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- KUTXFBIHPWIDJQ-BTPXSFBUSA-N (1ar,7as)-7a-methyl-1a-[(e,7r,11r)-3,7,11,15-tetramethylhexadec-2-enyl]naphtho[2,3-b]oxirene-2,7-dione Chemical compound O=C1C2=CC=CC=C2C(=O)[C@@]2(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@]1(C)O2 KUTXFBIHPWIDJQ-BTPXSFBUSA-N 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title abstract 2
- 208000028990 Skin injury Diseases 0.000 title 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 title 1
- 239000003581 cosmetic carrier Substances 0.000 abstract 2
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31988703P | 2003-01-20 | 2003-01-20 | |
| EP03447019A EP1442738A1 (de) | 2003-01-28 | 2003-01-28 | Dermatologische kosmetische Zusammensetzung enthaltend Vitamin K1 Oxid |
| PCT/BE2004/000011 WO2004064798A1 (en) | 2003-01-20 | 2004-01-20 | Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004016292D1 true DE602004016292D1 (de) | 2008-10-16 |
Family
ID=32773677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004016292T Expired - Lifetime DE602004016292D1 (de) | 2003-01-20 | 2004-01-20 | Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7939568B2 (de) |
| EP (1) | EP1594456B1 (de) |
| JP (1) | JP2006515873A (de) |
| KR (1) | KR20050103906A (de) |
| CN (1) | CN100531727C (de) |
| AT (1) | ATE406868T1 (de) |
| CA (1) | CA2513324C (de) |
| DE (1) | DE602004016292D1 (de) |
| DK (1) | DK1594456T3 (de) |
| ES (1) | ES2314365T3 (de) |
| HK (1) | HK1087010A1 (de) |
| PT (1) | PT1594456E (de) |
| SI (1) | SI1594456T1 (de) |
| WO (1) | WO2004064798A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2885802A1 (fr) * | 2005-05-17 | 2006-11-24 | Oreal | Utilisation cosmetique de la vitamine k pour ameliorer la fonction barriere de la peau |
| WO2007092136A2 (en) | 2006-02-03 | 2007-08-16 | Exxonmobil Chemical Patents, Inc. | Process for generating alpha olefin comonomers |
| US8003839B2 (en) | 2006-02-03 | 2011-08-23 | Exxonmobil Chemical Patents Inc. | Process for generating linear apha olefin comonomers |
| CA2694318A1 (en) * | 2007-07-24 | 2009-05-22 | Viridis Biopharma Pvt Ltd. | Treatment of human disease conditions and disorders using vitamin k analogues and derivatives |
| JP6397818B2 (ja) * | 2013-07-01 | 2018-09-26 | 株式会社明治 | 飲食品等の光安定性の向上方法 |
| US9421297B2 (en) | 2014-04-02 | 2016-08-23 | Adhezion Biomedical, Llc | Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB744376A (en) * | 1952-03-08 | 1956-02-08 | Merck & Co Inc | Vitamin emulsions |
| US3070499A (en) * | 1960-09-19 | 1962-12-25 | Merck & Co Inc | Parenteral aqueous solutions of fat soluble vitamins |
| JPH05320039A (ja) | 1991-09-20 | 1993-12-03 | Taiyo Kagaku Co Ltd | 美白化粧料 |
| US5981601A (en) * | 1992-05-28 | 1999-11-09 | Centre For Molecular Biology And Medicine | Method for enhancing cellular bioenergy |
| AU674330B2 (en) * | 1992-06-30 | 1996-12-19 | Howard K. Shapiro | Composition containing amine and amine-related derivatives of benzoic acid and uses therefor including treating inflammatory diseases |
| US5510391A (en) * | 1993-10-22 | 1996-04-23 | Mayapple Holdings, Llc | Method of treating blood vessel disorders of the skin using vitamin K |
| US5540934A (en) * | 1994-06-22 | 1996-07-30 | Touitou; Elka | Compositions for applying active substances to or through the skin |
| US5945409A (en) * | 1995-03-10 | 1999-08-31 | Wilson T. Crandall | Topical moisturizing composition and method |
| AU2804297A (en) | 1996-04-22 | 1997-11-12 | Advanced Polymer Systems Inc. | Method of and composition for treating disorders of the skin using vitamin k |
| US6180136B1 (en) * | 1998-11-10 | 2001-01-30 | Idexx Laboratories, Inc. | Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
-
2004
- 2004-01-20 PT PT04703319T patent/PT1594456E/pt unknown
- 2004-01-20 CA CA2513324A patent/CA2513324C/en not_active Expired - Fee Related
- 2004-01-20 US US10/542,914 patent/US7939568B2/en not_active Expired - Lifetime
- 2004-01-20 EP EP04703319A patent/EP1594456B1/de not_active Expired - Lifetime
- 2004-01-20 SI SI200430948T patent/SI1594456T1/sl unknown
- 2004-01-20 CN CNB2004800024903A patent/CN100531727C/zh not_active Expired - Fee Related
- 2004-01-20 DK DK04703319T patent/DK1594456T3/da active
- 2004-01-20 JP JP2006500422A patent/JP2006515873A/ja active Pending
- 2004-01-20 WO PCT/BE2004/000011 patent/WO2004064798A1/en active IP Right Grant
- 2004-01-20 AT AT04703319T patent/ATE406868T1/de active
- 2004-01-20 DE DE602004016292T patent/DE602004016292D1/de not_active Expired - Lifetime
- 2004-01-20 ES ES04703319T patent/ES2314365T3/es not_active Expired - Lifetime
- 2004-01-20 KR KR1020057013381A patent/KR20050103906A/ko not_active Application Discontinuation
-
2006
- 2006-06-21 HK HK06107056.0A patent/HK1087010A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006515873A (ja) | 2006-06-08 |
| CA2513324A1 (en) | 2004-08-05 |
| US20060154983A1 (en) | 2006-07-13 |
| ES2314365T3 (es) | 2009-03-16 |
| EP1594456B1 (de) | 2008-09-03 |
| DK1594456T3 (da) | 2009-01-19 |
| WO2004064798A1 (en) | 2004-08-05 |
| ATE406868T1 (de) | 2008-09-15 |
| US7939568B2 (en) | 2011-05-10 |
| PT1594456E (pt) | 2008-12-16 |
| CN1738594A (zh) | 2006-02-22 |
| CA2513324C (en) | 2010-09-21 |
| EP1594456A1 (de) | 2005-11-16 |
| HK1087010A1 (en) | 2006-10-06 |
| KR20050103906A (ko) | 2005-11-01 |
| CN100531727C (zh) | 2009-08-26 |
| SI1594456T1 (sl) | 2009-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0502346A (pt) | processo de tratamento cosmético para prevenir e/ou tratar as peles sensìveis e/ou secas, utilização de uma quantidade eficaz de pelo menos um microorganismo notadamente probiótico e/ou uma de suas frações e/ou um de seus metabólitos e composição cosméticas e/ou dermatológica | |
| BR0113042A (pt) | Composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivìduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato | |
| ATE265456T1 (de) | 2-amino-6-anilino-purine und deren verwendung als arzneimittel | |
| BR0116832A (pt) | Produto desodorante, método cosmético e método de fabricação de composição desodorante | |
| DE50115490D1 (de) | Kosmetische zusammensetzung zur behandlung von alternder und/oder gestresster haut | |
| DE59907752D1 (de) | Verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien | |
| MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
| ATE552000T1 (de) | Verwendung von isothiocyanat-verbindungen zur behandlung von prostata-erkrankungen und hautkrebs | |
| ATE220536T1 (de) | Kosmetische und/oder dermatologische zusammensetzung enthaltend salicylsäure oder ihre derivate und ihre verwendung | |
| DE60135755D1 (de) | Verbindungen und methoden zur behandlung von hautverletzungen | |
| DE69911210D1 (de) | Verwendung von piperin und derivate davon zur behandlung von hautpigmentierungstörungen und hautkrebs | |
| ATE347401T1 (de) | Kosmetische verwendung einer zusammensetzung mit mindestens einem oxazolin als wirkstoff, als abnehmprodukt und/oder zur prävention und/oder behandlung von cellulite | |
| ATE415962T1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| DE60023816D1 (de) | Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen | |
| ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| DE602005016198D1 (de) | Verwendung von Hülsenfrüchten zur Herstellung von Produkten zum Schutz oder Behandlung von radiotherapie-bedingten Hautschäden | |
| NO975192D0 (no) | Bicykliske aromatiske forbindelser | |
| DE60316447D1 (de) | Flavonoidverbindungen als therapeutische antioxidationsmittel | |
| ATE425752T1 (de) | Verwendung von pipamperon und einem sndri, snri oder ssri zur behandlung von stimmungs- oder angststírungen | |
| CY1108607T1 (el) | Συνθεσεις περιλαμβανουσες ζελατινη-γλυκινη και καροτενοειδη | |
| DE69902520D1 (de) | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden | |
| DE69918972D1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| DE602004016292D1 (de) | Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| ATE126058T1 (de) | Dermatologische zusammensetzungen mit einem gehalt an cis-urocaninsäure. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |